Donor-derived strongyloidiasis after organ transplantation in Norway.
Adult
Allografts
/ parasitology
Animals
Antibodies, Helminth
/ isolation & purification
Antiparasitic Agents
/ therapeutic use
Humans
Kidney Transplantation
/ adverse effects
Male
Middle Aged
Norway
Pancreas Transplantation
/ adverse effects
Retrospective Studies
Strongyloides stercoralis
/ drug effects
Strongyloidiasis
/ diagnosis
Tissue Donors
Transplant Recipients
Treatment Outcome
Strongyloides stercoralis
donor-derived infection
hyperinfection syndrome
pre-transplant screening
solid organ transplantation
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
09
07
2018
revised:
28
08
2018
accepted:
02
10
2018
pubmed:
9
10
2018
medline:
6
4
2019
entrez:
9
10
2018
Statut:
ppublish
Résumé
Strongyloides stercoralis is an intestinal helminth which in humans can cause asymptomatic chronic infection maintained for decades through its auto-infective cycle. During solid organ transplantation, recipients may unintentionally receive an organ infected with strongyloides. This is a very rare complication but may have deadly outcome if not detected. We hereby report two transplant recipients whom developed Strongyloides hyperinfection syndrome after organ transplantation from the same deceased donor. Recipient 1 was kidney transplanted and presented at day 65 post engraftment with diarrhea and subsequent septicemia and gastric retention. Larvae were detected in gastric aspirate. Recipient 2 was simultaneously kidney and pancreas transplanted and presented at day 90 post engraftment also with gastric retention and septicemia. Larvae were demonstrated on duodenal biopsy and stool sample. The clinical course was complicated with severe duodenal bleedings, gastric retention, meningitis, and prolonged hospitalization. Retrospective testing of pre-transplant donor serum was positive for Strongyloides stercoralis antibodies. As a result of disease severity and gastric retention albenazole was administered via a jejunal tube and ivermectin subcutaneously in both recipients. S stercoralis was successfully eradicated and the transplants ended up with unaffected graft function. Following these two cases, we started systematic screening of all deceased donors for serum Strongyloides IgG in October 2016. After having screened 150 utilized donors one tested positive for Strongyloides, which initiated prophylactic ivermectin treatment to organ recipients. No symptoms or disease developed. Our center will continue to screen all donors as prophylactic treatment may avert this potentially lethal complication in cases of donor-derived Strongyloides infection.
Substances chimiques
Antibodies, Helminth
0
Antiparasitic Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13008Informations de copyright
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.